World Wires · story 105058 · corroborated · 1 source(s)

Wegovy sales beat expectations leading Novo Nordisk to raise 2026 outlook

Obesity drug Wegovy exceeds expectations, prompting Novo Nordisk to improve its financial forecast for 2026.

Open in the desk

Coverage

• Wegovy sales beat expectations leading Novo Nordisk to raise 2026 outlook El País América · tier B · clear net · 2026-11-04 10:29 UTC

What this site indexes